Moreover, the decrease in IGFBP5 and IGF1 expression seen in GDM was not paralleled by changes in other key angiogenic factor genes, such as VEGFA and FGF2, nor by significant inflammatory alterations as inferred by unchanged gene expression of the macrophage marker CD-68 (Fig. 3d). This evidence concerns the gene FGF2 and gestational diabetes.